Small PMMA beads improve gentamicin release

Area of Science:

• Biomaterials science
• Infectious disease research
• Drug delivery systems

Background:

• Polymethyl methacrylate (PMMA) beads are used for localized gentamicin delivery.
• Conventional 7-mm PMMA beads have limitations in drug release efficiency.
• Recently developed 3 x 5-mm minibeads offer a potential alternative.

Purpose of the Study:

• To compare the in vivo gentamicin base release from conventional 7-mm PMMA beads and new 3 x 5-mm minibeads.
• To evaluate the efficacy of minibeads for achieving bactericidal effects in bone cavities.

Main Methods:

• In vivo study comparing drug release profiles.
• Measurement of gentamicin release over a 14-day period.
• Comparison of bead volumes and total drug release.

Main Results:

• Minibeads released 93% of gentamicin content in 14 days, compared to 24% from large beads.
• Minibead volume is one-fifth that of large beads.
• Total gentamicin release from minibeads may be seven times greater than from large beads.

Conclusions:

• Gentamicin minibeads demonstrate superior in vivo release kinetics compared to conventional large beads.
• The combination of smaller size and enhanced release makes minibeads advantageous for localized gentamicin delivery.
• Minibeads are recommended for achieving potent bactericidal effects in smaller bone cavities.